Sun Pharmaceutical Industries Ltd
Sevelamer (400mg)
Revlamer 400 Tablet is used to treat increased phosphate levels in the blood in patients on dialysis due to severe kidney disease.
Tablet
Revlamer 400 Tablet is used to treat increased phosphate levels in the blood. It is used in patients who are on dialysis due to severe kidney disease. It inhibits the absorption of phosphate from the intestine and lowers the phosphate levels in the blood.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Revlamer 400 Tablet is to be taken with food.
No common side effects listed.
It is not known whether it is safe to consume alcohol with Revlamer 400 Tablet. Please consult your doctor.
Revlamer 400 Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Revlamer 400 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Mycophenolate mofetil Tacrolimus Ciclosporin
Revlamer 400 Tablet inhibits the absorption of phosphate from the intestine and lower the phosphate levels in the blood.
Revlamer 400 Tablet is used to control blood phosphate level in patients that are on dialysis treatment. You must take it with food and stick to the diet prescribed by your doctor. You may develop low levels of calcium, folic acid, and vitamins A, D, E, and K in your blood. Your doctor may prescribe supplements if necessary. Avoid taking any other medicine 1 hour before or 3 hours after taking Revlamer 400 Tablet. Inform your doctor if you have nausea, vomiting, constipation, pain in the abdomen, or if you have undergone any major stomach surgery.
Yes, Revlamer 400 Tablet can be taken with food. It is recommended to take 1-2 tablets (based on individual needs) thrice daily. It is important to take it with meals because Revlamer 400 Tablet works by binding to phosphate from food. Take it exactly as advised by your doctor.
No, you should not crush, chew, or break Revlamer 400 Tablet into pieces. You should swallow it as a whole with water.
It is essential to take Revlamer 400 Tablet because patients undergoing dialysis cannot control phosphate levels in their blood, especially after a meal. When the phosphate level exceeds the range in the blood, problems may occur such as itchy skin, red eyes, high blood pressure, bone pain, and an increased risk of fractures. These elevated serum phosphate levels are reduced by Revlamer 400 Tablet by binding to phosphate from food in the digestive tract.
A common side effect of Revlamer 400 Tablet is constipation, though it does not occur in everyone. Other common gastrointestinal side effects include diarrhea, indigestion, flatulence, and abdominal pain. Consult your doctor immediately if these side effects become severe and disruptive.
Patients with known allergies to Revlamer 400 Tablet and those with low phosphate levels in their blood should avoid taking it. Additionally, patients experiencing intestinal obstruction should also avoid using Revlamer 400 Tablet.
Ciprofloxacin may interfere with the working of Revlamer 400 Tablet, and it should not be taken at the same time as Revlamer 400 Tablet. However, if taken together, a gap of at least 2 hours before or 6 hours after taking Revlamer 400 Tablet should be maintained.
Continue taking Revlamer 400 Tablet as advised by your doctor. Revlamer 400 Tablet lowers dietary phosphate levels but does not cure the underlying disease; therefore, you may need to take it for life. Stopping Revlamer 400 Tablet may increase your phosphate levels.
Regular monitoring of serum phosphate levels is necessary while taking Revlamer 400 Tablet. Additionally, the use of Revlamer 400 Tablet may decrease the levels of vitamin D, A, E, K, and folic acid. Therefore, these levels need to be monitored during treatment.